In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SMEs (small and medium-sized enterprises) see benefit from UK Patents Bill:

This article was originally published in Clinica

Executive Summary

The UK Patents Bill was passed by parliament on July 14, at the third reading. It incorporates a clause (amending section 106 of the Patents Act 1977) that aims to "make a small additional improvement to the framework for enforcement of patent rights" and an amendment which seek to address the concerns particularly of small and medium-sized enterprises (SMEs). The changes "aim to help SMEs in appropriate circumstances where they face litigation in the courts", taking into account the need for the framework to be "accessible to an SME patent holder, but which is also fair to a party against whom enforcement action may be taken, [which] may be another SME".

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT059134

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel